Eric P. Milledge

Président chez

CeQur Corp.

Health Technology

Health Services

Finance

Profil

Eric P.
Milledge is currently the Executive Chairman at CeQur Corp., Director at ReShape Medical, Inc., Director at CeQur SA, and Director at Glassbeam, Inc. He previously served as the Chairman & Chief Executive Officer at Nfocus Neuromedical, Inc., Chairman at Lifescan, Inc., Chairman at Symetis SA, Director at Glassbeam, Inc., Principal at Johnson & Johnson, Operating Partner at Endeavour Vision SA, and President at Ortho Pharmaceutical Corp.

Postes actifs de Eric P. Milledge

Sociétés	Poste	Début
CeQur SA CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients	Directeur/Membre du Conseil	-
ReShape Medical, Inc. ReShape Medical, Inc. Medical SpecialtiesHealth Technology Develops non-surgical medical devices for the treatment of obesity	Directeur/Membre du Conseil	-
CeQur Corp. CeQur Corp. Miscellaneous ManufacturingProducer Manufacturing Designs, manufactures and commercializes disposable wearable insulin infuser	Président	-
Glassbeam, Inc. Glassbeam, Inc. Packaged SoftwareTechnology Services Develops healthcare software platform	Directeur/Membre du Conseil	01/05/2023

Tous les postes actifs de Eric P. Milledge

Anciens postes connus de Eric P. Milledge

Sociétés	Poste	Fin
SYMETIS SA	Président	-
Glassbeam, Inc. Glassbeam, Inc. Packaged SoftwareTechnology Services Develops healthcare software platform	Directeur/Membre du Conseil	-
Endeavour Vision SA Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired.	Private Equity Investor	-
Nfocus Neuromedical, Inc. Nfocus Neuromedical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets neurovascular devices	Directeur Général	-
Ortho Pharmaceutical Corp.	President	-

Voir l'expérience en détail de Eric P. Milledge

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Eric P. Milledge

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	10
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
ReShape Medical, Inc. ReShape Medical, Inc. Medical SpecialtiesHealth Technology Develops non-surgical medical devices for the treatment of obesity	Health Technology
Lifescan, Inc. Lifescan, Inc. Medical/Nursing ServicesHealth Services Manufactures health care products	Health Services
Symetis SA Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications	Health Technology
Nfocus Neuromedical, Inc. Nfocus Neuromedical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets neurovascular devices	Health Technology
Endeavour Vision SA Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired.	Finance
Ortho Pharmaceutical Corp.
CeQur SA CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients	Health Technology
Glassbeam, Inc. Glassbeam, Inc. Packaged SoftwareTechnology Services Develops healthcare software platform	Technology Services
CeQur Corp. CeQur Corp. Miscellaneous ManufacturingProducer Manufacturing Designs, manufactures and commercializes disposable wearable insulin infuser	Producer Manufacturing